Shares of Roche Holding AG (OTCMKTS:RHHBY – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $51.67 and last traded at $51.43, with a volume of 2821543 shares trading hands. The stock had previously closed at $51.20.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on RHHBY. Deutsche Bank Aktiengesellschaft upgraded Roche from a “sell” rating to a “hold” rating in a report on Tuesday, November 11th. JPMorgan Chase & Co. raised Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th. Hsbc Global Res upgraded Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 2nd. Morgan Stanley reiterated an “underweight” rating on shares of Roche in a research note on Tuesday, December 2nd. Finally, Jefferies Financial Group lowered shares of Roche from a “hold” rating to a “moderate sell” rating in a research report on Monday, October 27th. Three equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Roche has a consensus rating of “Moderate Buy” and an average price target of $57.00.
View Our Latest Analysis on RHHBY
Roche Stock Down 0.1%
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Rhumbline Advisers lifted its stake in Roche by 7.4% in the first quarter. Rhumbline Advisers now owns 107,252 shares of the company’s stock valued at $4,413,000 after purchasing an additional 7,374 shares during the last quarter. OLD National Bancorp IN increased its position in Roche by 2.9% in the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after buying an additional 7,326 shares during the last quarter. Enterprise Financial Services Corp bought a new stake in shares of Roche in the second quarter valued at $208,000. North Star Asset Management Inc. raised its stake in shares of Roche by 52.0% in the second quarter. North Star Asset Management Inc. now owns 26,305 shares of the company’s stock valued at $1,072,000 after buying an additional 9,000 shares during the period. Finally, FineMark National Bank & Trust purchased a new position in shares of Roche during the 2nd quarter valued at $210,000.
Roche Company Profile
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.
Featured Stories
- Five stocks we like better than Roche
- How Long Will $1M Last in Retirement?
- The Best $1 You’ll Spend This Holiday Season
- Washington prepares for war
- GOLD ALERT
- Punch these codes into your ordinary brokerage account
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
